Home
About
Overview
Sharing Data
ORCID
Help
History (1)
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Urologe A. 2004 Sep; 43 Suppl 3:S137.
View in:
PubMed
subject areas
Alleles
Alleles
Antigens, Neoplasm
Antigens, Neoplasm
Carcinoma, Renal Cell
Carcinoma, Renal Cell
Cytokines
Cytokines
Disease-Free Survival
Disease-Free Survival
Gene Frequency
Gene Frequency
Genetic Carrier Screening
Genetic Carrier Screening
Genotype
Genotype
Haplotypes
Haplotypes
Histocompatibility Antigens Class II
Histocompatibility Antigens Class II
Histocompatibility Testing
Histocompatibility Testing
Homozygote
Homozygote
Humans
Humans
Kidney Neoplasms
Kidney Neoplasms
Neoplasm Metastasis
Neoplasm Metastasis
Prognosis
Prognosis
Treatment Outcome
Treatment Outcome